EMCURE
Invest Now

Emcure Pharmaceuticals Share Price
₹1,098.80 +90.5 (8.98%)
19 Apr, 2025 11:17
Start SIP in
EMCURE
Performance
- Low
- ₹1,009
- High
- ₹1,109
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,580
- Open Price₹1,011
- Previous Close₹1,008
- Volume529,139
Investment Returns
- Over 1 Month + 17.2%
- Over 3 Month -19.32%
- Over 6 Month -26.44%
- Over 1 Year + 9.01%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 34.3
- PEG Ratio
- -
- Market Cap Cr
- 20,820
- P/B Ratio
- 5.1
- Average True Range
- 62.09
- EPS
- 32.07
- Dividend Yield
- 0
- MACD Signal
- -15.56
- RSI
- 61.48
- MFI
- 84.95
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,098.80
+
90.5
(8.98%)

-
- Bearish Moving Average 3
-
- Bullish Moving Average 11
- 20 Day
- ₹996.97
- 50 Day
- ₹1,050.98
- 100 Day
- ₹1,144.04
- 200 Day
- -
Resistance and Support
1072.13
- R3 1,236.37
- R2 1,172.73
- R1 1,135.77
- S1 1,035.17
- S2 971.53
- S3 934.57
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-06 | Quarterly Results | |
2024-11-07 | Quarterly Results | |
2024-08-13 | Quarterly Results |
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,098 As on 19 April, 2025 | 11:03
The Market Cap of Emcure Pharmaceuticals is ₹20820.4 Cr As on 19 April, 2025 | 11:03
The P/E ratio of Emcure Pharmaceuticals is 34.3 As on 19 April, 2025 | 11:03
The PB ratio of Emcure Pharmaceuticals is 5.1 As on 19 April, 2025 | 11:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.